ArriVent BioPharma, Inc. AVBP Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from ArriVent BioPharma, Inc.’s reported figures.
Based on the most recent quarter.
The official record: ArriVent BioPharma, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about ArriVent BioPharma, Inc.'s cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ArriVent BioPharma, Inc.'s cash ratio?
- ArriVent BioPharma, Inc. (AVBP) reported cash ratio of 2.5× in Q1 2026.
- How has ArriVent BioPharma, Inc.'s cash ratio changed year-over-year?
- ArriVent BioPharma, Inc.'s cash ratio decreased by 35.5% year-over-year, from 3.8× to 2.5×.
- What is the long-term trend for ArriVent BioPharma, Inc.'s cash ratio?
- Over 2 years (2023 to 2025), ArriVent BioPharma, Inc.'s cash ratio has grown at a -63.2% compound annual growth rate (CAGR), from 12.9× to 1.8×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.